Omeprazole: NHS prescribing information and patient guidance

Omeprazole is one of the most frequently prescribed medications in NHS primary care. As a prescribing doctor, I can outline how the process works and what patients can expect.

Prescription strengths available on the NHS:

• Omeprazole 10 mg capsules
• Omeprazole 20 mg capsules (most commonly prescribed)
• Omeprazole 40 mg capsules
• Omeprazole 10 mg dispersible (MUPS) tablets
• Omeprazole 20 mg dispersible (MUPS) tablets
• Omeprazole 40 mg dispersible (MUPS) tablets

Most NHS prescriptions are for generic omeprazole capsules, which are highly cost-effective. Branded versions (such as Losec) are available but rarely prescribed due to cost considerations.

How to obtain a prescription:

1. Book an appointment with your GP if you have persistent symptoms of acid reflux, heartburn or dyspepsia
2. Your GP will assess your symptoms and may prescribe a 4-to-8-week course
3. For ongoing prescriptions, many practices offer repeat prescribing with annual review
4. Some pharmacists can now supply PPIs under the Pharmacy First service for minor conditions

The NHS prescription charge in England is currently a standard per-item fee. In Scotland, Wales and Northern Ireland, prescriptions are free.

Patients with a prepayment certificate may find this more economical for multiple medications.

Omeprazole is available both on prescription and over the counter (OTC), but there are important differences that patients should understand.

Over-the-counter (pharmacy sale):

• Available as omeprazole 10 mg or 20 mg
• Sold under various brand names including Pyrocalm Control and Zanprol
• Intended for short-term treatment of reflux symptoms (maximum 2 weeks)
• Suitable for adults aged 18 and over
• No prescription required; available from pharmacies with pharmacist advice
• Cost: typically around three to five pounds for a 14-day supply

Prescription only:

• Higher doses (40 mg) require a prescription
• Longer treatment courses (beyond 2 weeks) should be supervised by a doctor
• Specific indications such as ulcer healing, H. pylori eradication and Zollinger-Ellison syndrome require prescription
• Paediatric use requires a prescription

When to move from OTC to prescription:

I advise patients to consult their GP if:

• OTC omeprazole does not relieve symptoms after 2 weeks
• Symptoms recur frequently after stopping
• They have alarm symptoms (difficulty swallowing, unintended weight loss, vomiting blood, black stools)
• They are over 55 with new-onset dyspepsia

NICE recommends that patients with persistent symptoms should be assessed for H. pylori and, if appropriate, referred for upper GI endoscopy.

NICE Clinical Guideline CG184 provides comprehensive recommendations for the use of PPIs, including omeprazole, in the management of GORD and dyspepsia.

Key NICE recommendations:

• First-line PPI: omeprazole is recommended as a first-line PPI for most indications due to its established efficacy, safety profile and cost-effectiveness
• Lowest effective dose: prescribe the lowest dose that controls symptoms and review regularly
• Step-down therapy: after initial healing, attempt to reduce the dose or switch to as-needed use
• Annual review: all patients on long-term PPIs should have their prescription reviewed at least annually
• H. pylori testing: test for H. pylori before starting long-term PPI therapy, as eradication may resolve symptoms

NICE recommendations for specific conditions:

• Uninvestigated dyspepsia: 4-week PPI trial with H. pylori testing
• GORD without oesophagitis: step-down to lowest effective dose after symptom control
• Erosive oesophagitis: treatment for 4 to 8 weeks, then maintenance at lowest effective dose
• Barrett's oesophagus: ongoing full-dose PPI therapy is recommended

These guidelines emphasise that PPIs should not be continued indefinitely without review.

In my practice, I follow NICE guidance by scheduling medication reviews and actively attempting dose reduction where clinically appropriate.

The NHS has placed increasing emphasis on structured medication reviews, and PPIs are a key target for deprescribing initiatives.

Structured Medication Reviews (SMRs):

Since the introduction of the Network Contract DES, PCN clinical pharmacists conduct SMRs for patients on long-term medications. PPIs are specifically flagged for review.

• Confirm the original indication for the PPI
• Assess whether the indication still applies
• Check for potential side effects and drug interactions
• Discuss dose reduction or trial withdrawal if appropriate

What to expect at your review:

If you are called for a medication review, your pharmacist or GP will discuss:

1. Why you were originally prescribed omeprazole
2. Whether your symptoms are currently controlled
3. Whether a lower dose might be sufficient
4. Whether you could try stopping with antacids as rescue therapy
5. Any monitoring blood tests needed (magnesium, B12, renal function)

I encourage patients to engage positively with these reviews. Many patients are relieved to learn they can safely reduce or stop a medication they have been taking for years.

NHS savings:

PPI deprescribing is also a significant cost-saving opportunity for the NHS.

Reducing unnecessary long-term PPI prescribing is estimated to save millions of pounds annually while improving patient outcomes.

While omeprazole is a safe and effective medication for most patients, there are specific situations where you should seek medical advice rather than self-managing.

See your GP if:

• You have been buying omeprazole over the counter for more than 2 weeks without improvement
• Your symptoms have changed or worsened
• You are experiencing new difficulty swallowing (dysphagia)
• You have unintentional weight loss
• You are over 55 with new-onset indigestion
• You are vomiting blood or passing black, tarry stools
• You are taking medications that may interact with omeprazole (such as clopidogrel)
• You are pregnant or planning pregnancy and want advice on acid reflux management

Urgent referral criteria:

NICE recommends urgent (2-week wait) referral for upper GI endoscopy if you have:

• Dysphagia at any age
• Upper abdominal mass
• Age 55 or over with unexplained weight loss and any of: upper abdominal pain, reflux, or dyspepsia

Your GP is always the best point of contact for concerns about omeprazole or any other medication. You can also speak to your community pharmacist for advice about minor side effects and OTC use.